DE69332576T2 - Glykolisierte Cytokine - Google Patents

Glykolisierte Cytokine

Info

Publication number
DE69332576T2
DE69332576T2 DE69332576T DE69332576T DE69332576T2 DE 69332576 T2 DE69332576 T2 DE 69332576T2 DE 69332576 T DE69332576 T DE 69332576T DE 69332576 T DE69332576 T DE 69332576T DE 69332576 T2 DE69332576 T2 DE 69332576T2
Authority
DE
Germany
Prior art keywords
galactose
interferon
cytokine
modified
ifn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332576T
Other languages
German (de)
English (en)
Other versions
DE69332576D1 (de
Inventor
Kazuhiro Doken
Naoru Hamaguchi
Jun Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69332576D1 publication Critical patent/DE69332576D1/de
Publication of DE69332576T2 publication Critical patent/DE69332576T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69332576T 1992-09-24 1993-09-18 Glykolisierte Cytokine Expired - Fee Related DE69332576T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25496292 1992-09-24
JP8892093 1993-04-15

Publications (2)

Publication Number Publication Date
DE69332576D1 DE69332576D1 (de) 2003-01-30
DE69332576T2 true DE69332576T2 (de) 2003-11-20

Family

ID=26430256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332576T Expired - Fee Related DE69332576T2 (de) 1992-09-24 1993-09-18 Glykolisierte Cytokine

Country Status (9)

Country Link
US (1) US5643564A (cg-RX-API-DMAC10.html)
EP (1) EP0589378B1 (cg-RX-API-DMAC10.html)
KR (1) KR940007058A (cg-RX-API-DMAC10.html)
CN (1) CN1087916A (cg-RX-API-DMAC10.html)
AT (1) ATE229981T1 (cg-RX-API-DMAC10.html)
CA (1) CA2106821A1 (cg-RX-API-DMAC10.html)
DE (1) DE69332576T2 (cg-RX-API-DMAC10.html)
PH (1) PH31582A (cg-RX-API-DMAC10.html)
TW (1) TW263437B (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン
IL116730A0 (en) * 1995-01-13 1996-05-14 Amgen Inc Chemically modified interferon
WO1997007820A1 (fr) * 1995-08-30 1997-03-06 Toray Industries, Inc. Remede destine aux maladies cardiaques
AUPP660698A0 (en) * 1998-10-21 1998-11-12 University Of Queensland, The A method of protein engineering
AR078117A1 (es) 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
AU2012223210B2 (en) * 2011-03-02 2016-12-22 Board Of Regents Of The University Of Texas System Vesicle compositions
EP3129493B1 (en) 2014-04-09 2021-07-07 The Scripps Research Institute Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
IL321812A (en) 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386026A (en) * 1981-04-20 1983-05-31 Merck & Co., Inc. Cell-specific glycopeptide ligands
US4609546A (en) * 1982-06-24 1986-09-02 Japan Chemical Research Co., Ltd. Long-acting composition
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質,その製造法および中間体
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
US4829690A (en) * 1987-06-26 1989-05-16 Andros Theodore A Credit card chain holder
JPH01102098A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 糖鎖修飾糖タンパク質
JPH01102099A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 生理活性を有する糖タンパク質
US4902502A (en) * 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
JPH03106900A (ja) * 1989-09-20 1991-05-07 Toray Ind Inc 糖鎖修飾ヒトインターフェロン集合体
JPH085914B2 (ja) * 1990-02-16 1996-01-24 株式会社ディ・ディ・エス研究所 グリコシル−蛋白誘導体
US5096816A (en) * 1990-06-05 1992-03-17 Cetus Corporation In vitro management of ammonia's effect on glycosylation of cell products through pH control
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン

Also Published As

Publication number Publication date
ATE229981T1 (de) 2003-01-15
EP0589378B1 (en) 2002-12-18
US5643564A (en) 1997-07-01
CA2106821A1 (en) 1994-03-25
PH31582A (en) 1998-11-03
CN1087916A (zh) 1994-06-15
EP0589378A2 (en) 1994-03-30
TW263437B (cg-RX-API-DMAC10.html) 1995-11-21
EP0589378A3 (en) 1995-02-22
KR940007058A (ko) 1994-04-26
DE69332576D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
US5723121A (en) Sugar modified interferon
DE69430251T2 (de) Verbesserte interferon-polymerkonjugate
DE3520228C2 (de) Wasserlösliche bioaktive Trockenfeststoffzusammensetzung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE69632062T2 (de) Kontinuierliche, niedrigdosierte zytokine-infusionstherapie
DE69330087T2 (de) System zur lokalisierung und kommunikation mit mobilen fahrzeugen
DE68923723T3 (de) Modifizierter humaner G-CSF.
US5346696A (en) Asialoglycoprotein - conjugated medicinal agent
DE69520088T2 (de) Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten
DE3855899T2 (de) Prozess zur gewinnung von mikrobiell produziertem interleukin-2
DE3751527T2 (de) Zusammensetzungen zur Modulation der Effekten von TNF und IL-1.
DE69628838T2 (de) Chemokin bindendes protein und verfahren zu seiner verwendung
DE69232586T2 (de) Giftigkeit von tnf und lps ausschaltende peptide
DE69712036T2 (de) Neue verabreichung von thrombopoietin
CH681625A5 (cg-RX-API-DMAC10.html)
EP0529300A1 (de) Neues rekombinantes Human-IFN-beta, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
EP0589378B1 (en) Glycosylated cytokines
DE69331977T2 (de) Löslicher LDL-Rezeptor, seine Herstellung und Verwendung
EP2217619B1 (de) Zyklisches, cystein-freies protein
DE69824358T2 (de) Peptidfragment von LALF mit antiviraler Wirkung
JPH10513440A (ja) 化学的に修飾したインターフェロン
DE3515336C2 (de) Verfahren zur Herstellung und Reinigung von â-Interferon
BRPI0822530A2 (pt) hormônio do crescimento modificado por polietileno glicol de fita dupla, método de preparação e sua aplicação
DE3887889T2 (de) Verfahren zur Gewinnung von mikrobiell hergestelltem Beta-Interferon.
ES2393783T3 (es) Polipéptidos del interferón-beta-1b humano recombinante mejorados
US5534251A (en) Stabilized il-1α medicinal composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee